Skip to main content
. 2024 Mar 21;44(4):469–490. doi: 10.1002/cac2.12534

FIGURE 6.

FIGURE 6

hnRNPA2B1 increased the self‐renewal and tumorigenic capacities of GCSCs in vitro. (A‐B) Representative images (A) and quantification (B) of the sphere‐forming abilities of SGC7901ADR, SGC7901VCR and SGC7901 at the indicated passages. Scale bar, 200 µm. (C) Representative images of CD133 /hnRNPA2B1 (left) and CD44/hnRNPA2B1 (right) immunostaining in SGC7901ADR, SGC7901VCR and SGC7901 tumor spheroids. Scale bars, 50 µm. The P value was calculated by one‐way ANOVA test (B left and middle) and paired t test (B right). *P < 0.05, ** P < 0.01, *** P < 0.001. Abbreviations: A2B1, heterogeneous nuclear ribonucleoprotein A2B1; CD133, cluster of differentiation 133; CD44, cluster of differentiation 44; GCSC, gastric cancer stem cell; lv‐NC, empty overexpression control; lv‐A2B1, overexpression of hnRNPA2B1; shNC, negative control short hairpin RNA; shA2B1, short hairpin RNA of hnRNPA2B1.